New Results
mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5
View ORCID ProfileEmanuele Andreano, View ORCID ProfileIda Paciello, Giulio Pierleoni, View ORCID ProfileGiuseppe Maccari, Giada Antonelli, Valentina Abbiento, View ORCID ProfilePiero Pileri, Linda Benincasa, Ginevra Giglioli, View ORCID ProfileGiulia Piccini, View ORCID ProfileConcetta De Santi, View ORCID ProfileClaudia Sala, View ORCID ProfileDuccio Medini, View ORCID ProfileEmanuele Montomoli, View ORCID ProfilePiet Maes, View ORCID ProfileRino Rappuoli
doi: https://doi.org/10.1101/2022.08.04.502828
Emanuele Andreano
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Ida Paciello
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Giulio Pierleoni
2VisMederi Research S.r.l., Siena, Italy
Giuseppe Maccari
3Data Science for Health (DaScH) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Giada Antonelli
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Valentina Abbiento
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Piero Pileri
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Linda Benincasa
2VisMederi Research S.r.l., Siena, Italy
Ginevra Giglioli
2VisMederi Research S.r.l., Siena, Italy
Giulia Piccini
4VisMederi S.r.l, Siena, Italy
Concetta De Santi
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Claudia Sala
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Duccio Medini
4VisMederi S.r.l, Siena, Italy
Emanuele Montomoli
2VisMederi Research S.r.l., Siena, Italy
4VisMederi S.r.l, Siena, Italy
5Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
Piet Maes
6KU Leuven, Rega Institute, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
Rino Rappuoli
1Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
7Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy
Article usage
Posted August 05, 2022.
mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5
Emanuele Andreano, Ida Paciello, Giulio Pierleoni, Giuseppe Maccari, Giada Antonelli, Valentina Abbiento, Piero Pileri, Linda Benincasa, Ginevra Giglioli, Giulia Piccini, Concetta De Santi, Claudia Sala, Duccio Medini, Emanuele Montomoli, Piet Maes, Rino Rappuoli
bioRxiv 2022.08.04.502828; doi: https://doi.org/10.1101/2022.08.04.502828
mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5
Emanuele Andreano, Ida Paciello, Giulio Pierleoni, Giuseppe Maccari, Giada Antonelli, Valentina Abbiento, Piero Pileri, Linda Benincasa, Ginevra Giglioli, Giulia Piccini, Concetta De Santi, Claudia Sala, Duccio Medini, Emanuele Montomoli, Piet Maes, Rino Rappuoli
bioRxiv 2022.08.04.502828; doi: https://doi.org/10.1101/2022.08.04.502828
Subject Area
Subject Areas
- Biochemistry (11740)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17410)
- Clinical Trials (138)
- Developmental Biology (9420)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12239)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28070)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)